1 Department of Audiology and Speech Pathology, The University of Melbourne, 550 Swanston Street, Parkville 3010 Australia
2 Department of Neurology, The University of California (Irvine), 200 S. Manchester Ave., Suite 206, Orange, CA 92868-4280, USA.
Brain. 2015 Nov;138(Pt 11):3141-58. doi: 10.1093/brain/awv270. Epub 2015 Oct 12.
The effects of inner ear abnormality on audibility have been explored since the early 20th century when sound detection measures were first used to define and quantify 'hearing loss'. The development in the 1970s of objective measures of cochlear hair cell function (cochlear microphonics, otoacoustic emissions, summating potentials) and auditory nerve/brainstem activity (auditory brainstem responses) have made it possible to distinguish both synaptic and auditory nerve disorders from sensory receptor loss. This distinction is critically important when considering aetiology and management. In this review we address the clinical and pathophysiological features of auditory neuropathy that distinguish site(s) of dysfunction. We describe the diagnostic criteria for: (i) presynaptic disorders affecting inner hair cells and ribbon synapses; (ii) postsynaptic disorders affecting unmyelinated auditory nerve dendrites; (iii) postsynaptic disorders affecting auditory ganglion cells and their myelinated axons and dendrites; and (iv) central neural pathway disorders affecting the auditory brainstem. We review data and principles to identify treatment options for affected patients and explore their benefits as a function of site of lesion.
自 20 世纪初首次使用声音检测措施来定义和量化“听力损失”以来,人们一直在探索内耳异常对可听度的影响。20 世纪 70 年代,耳蜗毛细胞功能(耳蜗微音器电位、耳声发射、总和电位)和听神经/脑干活动(听性脑干反应)的客观测量方法的发展,使得区分突触和听神经障碍与感觉受体丧失成为可能。当考虑病因和治疗方法时,这种区别至关重要。在这篇综述中,我们讨论了听觉神经病的临床和病理生理学特征,这些特征可区分功能障碍的部位。我们描述了以下诊断标准:(i)影响内毛细胞和带状突触的突触前障碍;(ii)影响无髓鞘听神经树突的突触后障碍;(iii)影响听神经节细胞及其有髓轴突和树突的突触后障碍;(iv)影响听觉脑干的中枢神经通路障碍。我们回顾了数据和原则,以确定受影响患者的治疗选择,并探讨了其作为病变部位的功能的益处。